Instead, when we examined the binding of FUS-CHOP to a target sequence, FN125 by ChIP we found that trabectedin caused the detachment of the chimera only in the sensitive tumour and not in the resistant ML017/ET. This evidence concerns the gene FUS and neoplasm.